Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01516853 · ClinicalTrials.gov registry record
Non-invasive Quantification of Liver Iron With MRI
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 50
- Enrollment target
NCT01516853: Completed study, sponsored by University of Wisconsin, Madison.
NCT01516853 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01516853 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to validate magnetic resonance imaging as a biomarker of hepatic iron concentration (HIC). Excessive accumulation of iron in the body is highly toxic, specifically in the liver. Accurate, non-invasive assessment of HIC is needed for diagnosis, quantitative staging and treatment monitoring or hepatic iron overload.
Primary Outcome
Accuracy of non-contrast R2\*-MRI for measuring hepatic iron concentration.
Interventions
- DEVICE Non-contrast MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-06 |
What the finished NCT01516853 record still lists
NCT01516853 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non-contrast MRI is the first listed.
NCT01516853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01516853 about?
NCT01516853 is a clinical study titled "Non-invasive Quantification of Liver Iron With MRI". The purpose of this study is to validate magnetic resonance imaging as a biomarker of hepatic iron concentration (HIC). Excessive accumulation of iron in the body is highly toxic, specifically in the liver. Accurate, non-invasive assessment of HIC is needed for diagnosis, quantitative staging and tr...
What is the current status of trial NCT01516853?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01516853?
The interventions under investigation include: Non-contrast MRI (DEVICE).
Who is sponsoring clinical trial NCT01516853?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia